Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rogaine Extra Strength

This article was originally published in The Tan Sheet

Executive Summary

Pharmacia & Upjohn announces money-back guarantee for men not satisfied the 5% OTC minoxidil solution "has either stopped their hair loss or regrown hair after four months of proper use." The marketing effort appears partially to be in response to the success of Merck's oral anti-baldness treatment Propecia (finasteride). While Propecia has a small incidence of adverse sexual side effects, P&U notes Rogaine Extra Strength "did not cause sexual dysfunction in clinical trials." To participate, men must have purchased four bottles of Rogaine Extra Strength after July 31 and used the product as directed for four months, twice a day. They also must register with the program by mail. Rogaine Extra Strength, approved Nov. 14, 1997, stopped hair loss or regrew hair in four of five men in clinical trials. Results may occur at two months, or it may take up to four months for an effect, labeling states...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088804

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel